This inventor holds 2 USPTO granted patents. Top assignees: Consel National De Recherche Scientifique, National Research Council of Canada, Other. Active years: 1995-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,039 
1 out of 834,513 Years Active: 1995-2001
Title: Innovations and Contributions of Jean-Michel Biquard
Introduction
Jean-Michel Biquard is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of immunology, particularly in the development of novel peptides and processes for cancer treatment. With a total of 2 patents, his work has the potential to impact therapeutic strategies in oncology.
Latest Patents
One of his latest patents is titled "Peptides immunologically related to known viral protein." This invention involves peptides that are immunologically related to proteins expressed by a viral agent. The peptides are designed using protein informational analysis techniques, specifically the Fourier transform method, to create a sequence of amino acids that can elicit an immune response against a target antigen. The Fourier spectrum of the sequence contains frequencies that are characteristic of the target antigen, enhancing the potential for antibody formation.
Another significant patent is "Process for indirect targeted immunocytolysis." This process aims to treat cancer by conjugating an immunogenic sensitizing agent to a targeting agent that binds to aberrant cells, such as cancer cells. The conjugate is introduced into the body of a human or animal that has been immunized against the sensitizing agent. This binding triggers a complement cascade and/or an antibody-dependent T-cell-mediated response, leading to the destruction of the targeted cells.
Career Highlights
Jean-Michel Biquard has worked with esteemed organizations such as the National Research Council of Canada and the National Center for Scientific Research. His experience in these institutions has contributed to his expertise in immunology and peptide research.
Collaborations
Throughout his career, Biquard has collaborated with notable colleagues, including Velibor Krsmanovic and Jon P Durkin. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Jean-Michel Biquard's contributions to immunology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in cancer treatment and immunological research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile